Concepedia

Kathryn Kersey

KK

46

Publications

3K

Citations

26

H-Index

1985

Active since

Affiliations

Gilead Sciences (United States)(Current)

Medical University of Vienna

Johns Hopkins Medicine

Texas Liver Institute

The University of Texas Health Science Center at San Antonio

Kathryn Kersey is an author at Gilead Sciences (United States) specializing in medicine, hepatitis, and viral hepatitis.

Top concepts

Publications per year

1985–2024

46

Publications

46

Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: Results from randomized phase III STELLAR trials

Stephen A. Harrison, Vincent Wai‐Sun Wong, Takeshi Okanoue et al. · Journal of Hepatology · 2020 · 438 citations

, , +9

Noninvasive Tests Accurately Identify Advanced Fibrosis due to NASH: Baseline Data From the STELLAR Trials

Quentin M. Anstee, Eric Lawitz, Naim Alkhouri et al. · Hepatology · 2019 · 258 citations

The safety and effectiveness of ledipasvir−sofosbuvir in adolescents 12‐17 years old with hepatitis C virus genotype 1 infection

William F. Balistreri, Karen F. Murray, Philip Rosenthal et al. · Hepatology · 2016 · 195 citations · Full text

Sofosbuvir plus ribavirin for the treatment of chronic genotype 4 hepatitis C virus infection in patients of Egyptian ancestry

Peter Ruane, Dani Ain, Richard Stryker et al. · Journal of Hepatology · 2014 · 164 citations · Full text

Phase I study of the heat shock protein 90 inhibitor alvespimycin (KOS-1022, 17-DMAG) administered intravenously twice weekly to patients with acute myeloid leukemia

Jeffrey E. Lancet, Ivana Gojo, Michael Burton et al. · Leukemia · 2010 · 154 citations

, , +10

Rows per page

1–5 of 46